Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02646384 · ClinicalTrials.gov registry record · NA

Ovarian Tissue Cryopreservation in Children

A NA study of Cancer, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02646384: Active NA study of Cancer, sponsored by Mayo Clinic.

NCT02646384 is a NA study of Cancer that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02646384, a NA study of Cancer, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The Institutional Review Board (IRB) protocol is being designed to offer ovarian tissue cryopreservation to female pediatric patients (birth-17 years of age) with fertility threatening medical diagnoses or facing surgery, chemotherapy or radiation therapy that may cause loss of reproductive potential. Because this procedure is currently considered experimental, the establishment of an IRB protocol under which this opportunity can be offered is needed.

Conditions Studied

Interventions

  • PROCEDURE Ovarian tissue cryopreservation

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-03-16
Est. Completion 2040-01-22
Phase NA
Mayo Clinic

2,844 total trials

What the registry record for NCT02646384 still lists

NCT02646384 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Ovarian tissue cryopreservation is the first listed.

NCT02646384 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02646384 about?

NCT02646384 is a clinical study titled "Ovarian Tissue Cryopreservation in Children". The Institutional Review Board (IRB) protocol is being designed to offer ovarian tissue cryopreservation to female pediatric patients (birth-17 years of age) with fertility threatening medical diagnoses or facing surgery, chemotherapy or radiation therapy that may cause loss of reproductive potentia...

What is the current status of trial NCT02646384?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2017-03-16. Estimated completion is 2040-01-22.

What conditions does trial NCT02646384 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT02646384?

The interventions under investigation include: Ovarian tissue cryopreservation (PROCEDURE).

Who is sponsoring clinical trial NCT02646384?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02646384 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02646384's enrollment target sits among peer trials

100 313th of 615 higher than 287 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02646384, the US trial registry maintained by the National Library of Medicine. NCT02646384 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.